Loading...
XNAS
ASTH
Market cap1.19bUSD
Jun 10, Last price  
26.53USD
Name

Apollo Medical Holdings Inc

Chart & Performance

D1W1MN
P/E
27.57
P/S
0.58
EPS
0.96
Div Yield, %
Shrs. gr., 5y
4.93%
Rev. gr., 5y
31.37%
Revenues
2.03b
+77.82%
00001,057,3542,441,4523,896,5845,110,8067,776,13110,484,30532,989,74244,048,74057,427,701356,355,930519,908,000560,618,000370,248,000773,915,0001,144,163,0002,034,540,000
Net income
43m
-4.48%
-10,089-13,339-27,484-36,651-891,815-196,080-156,331-720,346-8,904,564-5,020,298-1,802,601-9,344,044-8,969,81625,801,84210,835,00014,116,000-23,752,00068,923,00045,171,00043,149,000
CFO
52m
-36.44%
-228-6,163-15,960-13,112-635,582-338,141-245,031-385,45557,956-1,478,205-271,910-1,839,125-8,139,07851,833,92325,496,00013,673,00046,163,00070,335,00082,128,00052,198,000

Profile

Apollo Medical Holdings, Inc., a physician-centric technology-powered healthcare company, provides medical care services. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients in California. The company was founded in 1994 and is headquartered in Alhambra, California.
IPO date
Apr 09, 1999
Employees
1,362
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2024‑122022‑122021‑122020‑122019‑122018‑122017‑122017‑032016‑03
Income
Revenues
2,034,540
 
1,144,163
47.84%
Cost of revenue
1,917,263
1,022,355
Unusual Expense (Income)
NOPBT
117,277
121,808
NOPBT Margin
5.76%
10.65%
Operating Taxes
30,886
40,875
Tax Rate
26.34%
33.56%
NOPAT
86,391
80,933
Net income
43,149
 
45,171
-34.46%
Dividends
(4,036)
(14,030)
Dividend yield
0.27%
1.04%
Proceeds from repurchase of equity
(937)
2,981
BB yield
0.06%
-0.22%
Debt
Debt current
15,279
4,785
Long-term debt
68,426
249,935
Deferred revenue
Other long-term liabilities
439,302
20,260
Net debt
(92,918)
(80,069)
Cash flow
Cash from operating activities
52,198
82,128
CAPEX
(8,031)
(22,940)
Cash from investing activities
(192,395)
(7,113)
Cash from financing activities
135,146
(20,085)
FCF
27,702
Balance
Cash
161,181
293,594
Long term investments
15,442
41,195
Excess cash
74,896
277,581
Stockholders' equity
83,773
198,450
Invested Capital
1,068,034
605,442
ROIC
8.09%
14.30%
ROCE
10.22%
14.89%
EV
Common stock shares outstanding
48,224
45,602
Price
31.53
 
29.59
-59.73%
Market cap
1,520,496
 
1,349,375
-58.10%
EV
1,225,020
1,285,292
EBITDA
145,204
139,351
EV/EBITDA
8.44
9.22
Interest
33,097
7,920
Interest/NOPBT
28.22%
6.50%